Supercharge Your Innovation With Domain-Expert AI Agents!

Methods of treating cancer using tigit inhibitors and anti-cancer agents

A technology of anticancer agent and therapy, applied in the field of using TIGIT inhibitor and anticancer agent to treat cancer

Inactive Publication Date: 2017-08-18
F HOFFMANN LA ROCHE & CO AG
View PDF50 Cites 5 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, many cancers are also interconnected with the immune system, as various immune cells are able to mount responses against cancer cells, but cancer cells also possess mechanisms to suppress or evade these responses

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Methods of treating cancer using tigit inhibitors and anti-cancer agents

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0028] I. General Technology

[0029] The techniques and procedures described or referred to herein are generally well understood and commonly employed by those skilled in the art, using conventional methods such as, for example, the widely utilized method described in Sambrook et al., Molecular Cloning: A Laboratory Manual 3d edition ( 2001) Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.; Current Protocols in Molecular Biology (F.M.Ausubel et al., (2003)); Series Methods in Enzymology (Academic Press, Inc.): PCR2: A Practical Approach (M.J.MacPherson, B.D.Hames and G.R.Taylor, (1995)), Harlow and Lane (1988) Antibodies, A Laboratory Manual, and Animal Cell Culture (R.I. Freshney, (1987)); Oligonucleotide Synthesis (M.J. Gait, 1984); Methods in Molecular Biology, Humana Press; Cell Biology: A Laboratory Notebook (ed. J.E. Cellis, 1998) Academic Press; Animal Cell Culture (ed. R.I. Freshney), 1987); Introduction to Cell and Tissue Culture (J.P. Mather and P.E.Rob...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The present disclosure provides methods comprising administering to the individual an effective amount of an agent that decreases or inhibits TIGIT expression and / or activity and an anti-cancer agent and / or an anti-cancer therapy. Further provided are kits comprising an anti-cancer agent, an agent that decreases or inhibits TIGIT expression and / or activity, or both, as well as instructions for use thereof.

Description

[0001] Cross references to related applications [0002] This application claims priority to U.S. Provisional Application Serial No. 62 / 025,394, filed July 16, 2014, the contents of which are hereby incorporated by reference in their entirety. [0003] Submission of a sequence listing as an ASCII text file [0004] The content of the following submission on ASCII text file is incorporated herein by reference in its entirety: Sequence Listing in Computer Readable Format (CRF) (File Name: 146392027240SEQLISTING.TXT, Date of Record: 9 Jul 2015, Size: 11 KB). [0005] field of invention [0006] The present disclosure relates to methods of treating cancer and / or tumor immunity by administering agents that reduce or inhibit TIGIT expression and / or activity and anticancer agents and / or anticancer therapies. [0007] Background of the invention [0008] Many immune-related diseases are known and have been extensively studied. Such diseases include immune-mediated inflammatory disea...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K39/395A61K31/7088A61P35/00
CPCA61K31/7088A61K45/06C07K16/2803A61K38/193A61K38/20A61K38/217A61K47/6851A61P35/00A61K38/00A61K39/39558Y02A50/30A61K39/001104A61K39/001129A61K39/001113A61K39/001128A61K39/00117A61K39/001119A61K39/001106A61K39/001109A61K39/001124A61K39/001166A61K39/00114A61K39/0011A61K39/001138A61K39/001141A61K2039/5158A61K2300/00A61K47/6803A61K2039/505A61K2039/545C07K16/30C07K2317/51C07K2317/515C07K2317/56C07K2317/76C12N15/1138C12N15/115C12N2310/11C12N2310/12C12N2310/14
Inventor J·L·格罗甘
Owner F HOFFMANN LA ROCHE & CO AG
Features
  • R&D
  • Intellectual Property
  • Life Sciences
  • Materials
  • Tech Scout
Why Patsnap Eureka
  • Unparalleled Data Quality
  • Higher Quality Content
  • 60% Fewer Hallucinations
Social media
Patsnap Eureka Blog
Learn More